补气活血通络汤联合低分子肝素对气虚血瘀型老年髋部骨折患者血栓前状态的疗效观察

Efficacy of Buqi Huoxue Tongluo Decoction Combined with Low-Molecular-Weight Heparin on Pre-Thrombotic State of Hip Fracture Elderly Patients with Qi Deficiency and Blood Stasis

  • 摘要: 目的   观察补气活血通络汤联合低分子肝素对气虚血瘀型老年髋部骨折患者血栓前状态的疗效及其安全性。方法   收集2018年8月至2019年8月在我科住院治疗的气虚血瘀型老年髋部骨折患者共60例,随机分为对照组和治疗1组、治疗2组各20例,对照组给予常规剂量低分子肝素治疗,治疗1组给予补气活血通络汤联合常规剂量低分子肝素治疗,治疗2组给予补气活血通络汤联合小剂量低分子肝素治疗,分别于治疗前后检测3组患者的血栓前状态指标D-二聚体(D-D)、纤维蛋白原降解产物(FDP)、血管性假血友病因子(vWF)、血清抗凝血酶原Ⅲ(AT-Ⅲ),观察中医证候积分变化,同时记录手术时间、出血量、输血量以及是否血栓形成等数据。结果   治疗后,治疗1组FDP、vWF、AT-Ⅲ改善优于对照组(P<0.05),治疗2组AT-Ⅲ改善优于对照组(P<0.05),2个治疗组间比较差异无统计学意义(P>0.05);2个治疗组证候积分改善优于对照组(P<0.05~0.01),2个治疗组间比较证候积分差异无统计学意义(P>0.05);2个治疗组出血量、输血量均少于对照组(P<0.05~0.01);3组血栓形成情况比较,差异无统计学意义(P>0.05)。结论   补气活血通络汤联合低分子肝素能有效纠正气虚血瘀型老年髋部骨折患者血栓前状态、预防深静脉血栓形成,同时能减少低分子肝素的用量及出血风险,安全、有效,值得临床推广。

     

    Abstract: OBJECTIVE   To observe the efficacy and safety of Buqi Huoxue Tongluo decoction combined with low-molecular-weight heparin on pre-thrombotic state of hip fracture elderly patients with qi deficiency and blood stasis.METHODS   A total of 60 hip fracture elderly inpatient with qi deficiency and blood stasis in our department from August 2018 to August 2019 were randomly divided into the control group, treatment group 1 (T1), and treatment group 2 (T2), 20 cases each group. The control group was given conventional dose of low-molecular-weight heparin, T1 was given Buqi Huoxue Tongluo decoction combined with conventional dose of low-molecular-weight heparin, while T2 was given Buqi Huoxue Tongluo decoction combined with small dose of low-molecular-weight heparin. The pre-thrombotic status indexes of D-dimer (D-D), fibrinogen degradation product (FDP), von Willebrand factor (vWF), serum antithrombin Ⅲ(AT-Ⅲ) were measured in the three groups before and after treatment. The changes in the traditional Chinese medicine (TCM) syndrome scores were observed. In addition, we also recorded the operation time, bleeding volume, blood transfusion volume and whether thrombosis was formed and some other data.RESULTS   After treatment, the improvement condition of FDP, vWF and AT-Ⅲ in treatment group 1 was better than those in the control group (P < 0.05), and the improvement condition of AT-Ⅲ in treatment group 2 was better than that in the control group (P < 0.05), but the difference between the two treatment groups was not statistically significant (P>0.05). The improvement condition of TCM syndrome score in the treatment groups was better than that in the control group (P < 0.05, P < 0.01), but the difference of syndrome score between the two treatment groups was not statistically significant (P>0.05). The amount of bleeding and blood transfusion in the treatment group was less than that in the control group (P < 0.05, P < 0.01). The difference was not statistically significant when comparing the thrombosis in the three groups (P>0.05).CONCLUSION   Buqi Huoxue Tongluo decoction combined with low molecular heparin can effectively improve the pre-thrombotic state, prevent deep vein thrombosis in hip fracture elderly patients with qi deficiency and blood stasis and reduce the dosage of low molecular heparin and the risk of bleeding, therefore the treatment is safe, effective, and worthy of clinical promotion.

     

/

返回文章
返回